glp-1 drugs market dynamics 2025 Receptor Agonist Size, Share, Growth, 2034 GLP-1 Market Trends and Global
Description
Li Q, Jia M, Yan Z, et al
We cover the clinical indications, metabolic and cardiovascular benefits, and potential limitations of these emerging and exciting therapies
The collaboration aims to advance the clinical development of this oral therapy, with the goal of offering a more accessible and patient-friendly alternative to the currently available injectable GLP-1 receptor agonists
[DOI] [PMC free article] [PubMed] [Google Scholar] 172.Pan W., et al
doi: 10.3181/00379727-102-25338
However, these data should be interpreted cautiously
